NOUR HEART INC has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets measurement, biotechnology and computer technology are MOLECULAR PROFILING INST INC, CARIS MPI INC and GENOMICS RES PARTNERS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Pharmaceuticals | |
#5 | Organic fine chemistry | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Elgebaly Salwa A | 7 |
#2 | Elgebaly Salwa Ahmed | 4 |
#3 | Sayed Marwa Matboli | 2 |
#4 | Schiffman Elliot | 1 |
#5 | Sheard Paul | 1 |
#6 | Salwa Elgebaly A | 1 |
#7 | Farghaly Ahmed | 1 |
Publication | Filing date | Title |
---|---|---|
US2020400684A1 | Nourin gene-based rna molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, stemi/nstemi and heart failure | |
US2020397757A1 | Cyclocreatine phosphate: a novel bioenergetic therapy to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases | |
US2019383809A1 | Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients | |
CA2790883A1 | Antibodies, compositions, and assays for detection of cardiac disease | |
US2007122847A1 | Mitochondrial markers of ischemia | |
WO2007038341A2 | Methods of organ protection | |
US2008242639A1 | Phosphagen synthesis | |
WO2006034232A2 | Diagnostic marker |